These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The use and acceptance of Other Scientifically Relevant Information (OSRI) in the U.S. Environmental Protection Agency (EPA) Endocrine Disruptor Screening Program. Bishop PL, Willett CE. Birth Defects Res B Dev Reprod Toxicol; 2014 Feb; 101(1):3-22. PubMed ID: 24151143 [Abstract] [Full Text] [Related]
12. Analysis of EPA's endocrine screening battery and recommendations for further review. Schapaugh AW, McFadden LG, Zorrilla LM, Geter DR, Stuchal LD, Sunger N, Borgert CJ. Regul Toxicol Pharmacol; 2015 Aug; 72(3):552-61. PubMed ID: 26044367 [Abstract] [Full Text] [Related]
13. Spanning regulatory silos in the U.S. EPA's Endocrine Disruptor Screening Program: Letter to the Editor re: Evans et al. "Should the scope of human mixture risk assessment span legislative and regulatory silos for chemicals?". Wegner S, Heiger-Bernays W, Dix D. Sci Total Environ; 2016 May 15; 553():671-672. PubMed ID: 26972864 [No Abstract] [Full Text] [Related]
17. Assessing utility of thyroid in vitro screening assays through comparisons to observed impacts in vivo. Eytcheson SA, Olker JH, Friedman KP, Hornung MW, Degitz SJ. Regul Toxicol Pharmacol; 2023 Oct 15; 144():105491. PubMed ID: 37666444 [Abstract] [Full Text] [Related]
18. Development, validation and integration of in silico models to identify androgen active chemicals. Manganelli S, Roncaglioni A, Mansouri K, Judson RS, Benfenati E, Manganaro A, Ruiz P. Chemosphere; 2019 Apr 15; 220():204-215. PubMed ID: 30584954 [Abstract] [Full Text] [Related]
19. A predictive data-driven framework for endocrine prioritization: a triazole fungicide case study. Paul Friedman K, Papineni S, Marty MS, Yi KD, Goetz AK, Rasoulpour RJ, Kwiatkowski P, Wolf DC, Blacker AM, Peffer RC. Crit Rev Toxicol; 2016 Oct 15; 46(9):785-833. PubMed ID: 27347635 [Abstract] [Full Text] [Related]